Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy

被引:20
|
作者
Harvie, MN
Campbell, IT
Thatcher, N
Baildam, A
机构
[1] S Manchester Univ Hosp NHS Trust, Univ Dept Anaesthesia, Manchester M20 2LR, Lancs, England
[2] S Manchester Univ Hosp NHS Trust, Univ Med Oncol, Manchester M20 2LR, Lancs, England
[3] S Manchester Univ Hosp NHS Trust, Univ Surg, Manchester M20 2LR, Lancs, England
关键词
body composition; dietary intake; energy expenditure; gender; nonsmall cell lung cancer; resting;
D O I
10.1046/j.1365-277X.2003.00459.x
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Men with nonsmall cell lung cancer (NSCLC) are more susceptible to weight loss than women. The composition and aetiology of these gender specific weight changes are not known. Methods Measurements of body mass, body composition and energy balance (resting energy expenditure and energy intake) were made in 15 men and six women before and after chemotherapy for NSCLC. Results Over the course of chemotherapy minimal weight change was observed in both men and women. Men increased body fat from 25.0 +/- 5.5 to 27.9 +/- 7.9% (P < 0.05) whereas fat free mass (FFM) tended to decrease (P = 0.063). There was no change in body fat or FFM in the women. In the men resting energy expenditure decreased over the course of chemotherapy from 113.2 +/- 15.9 to 105.1 +/- 10.1% of the value predicted from the Harris Benedict equation (P < 0.05). In the women resting energy expenditure (REE) did not alter. Conclusion Over the course of chemotherapy for NSCLC, men and women appear to have different patterns of change in body composition and in energy expenditure.
引用
收藏
页码:323 / 326
页数:4
相关论文
共 50 条
  • [31] Preoperative staging for advanced nonsmall cell lung cancer
    Fukuse, T
    Wada, H
    Tanaka, F
    Yanagihara, H
    Hirata, T
    Hitomi, S
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 957 - 960
  • [32] CHEMORADIATION IN ADVANCED NONSMALL CELL LUNG-CANCER
    PISCH, J
    BERSON, AM
    MALAMUD, S
    BEATTIE, EJ
    HARVEY, J
    VIKRAM, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (01): : 183 - 188
  • [33] TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER
    SHEPHERD, FA
    SEMINARS IN ONCOLOGY, 1994, 21 (04) : 7 - 18
  • [34] Refining the treatment of advanced nonsmall cell lung cancer
    Ogita, Shin
    Wozniak, Antoinette J.
    LUNG CANCER-TARGETS AND THERAPY, 2010, 1 : 9 - 22
  • [35] Immunotherapy combinations in advanced nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 73 - 79
  • [36] Gemcitabine for the treatment of advanced nonsmall cell lung cancer
    Toschi, Luca
    Cappuzzo, Federico
    ONCOTARGETS AND THERAPY, 2009, 2 : 209 - 217
  • [37] Changes in Weight and Body Composition in Women Receiving Chemotherapy for Breast Cancer
    Nissen, Mary Jo
    Shapiro, Alice
    Swenson, Karen K.
    CLINICAL BREAST CANCER, 2011, 11 (01) : 52 - 60
  • [38] ALTERNATING CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II STUDY
    NOGUE, M
    ARCUSA, A
    MORALES, S
    GUASCH, I
    FRANQUESA, R
    BOLEDA, M
    CIRERA, L
    BADIA, A
    CARDONA, MT
    GALLEN, M
    ONCOLOGY, 1993, 50 (04) : 235 - 237
  • [39] Phase II study of paclitaxel and irinotecan chemotherapy in patients with advanced nonsmall cell lung cancer
    Oshita, Fumihiro
    Saito, Haruhiro
    Yamada, Kouzo
    Noda, Kazumasa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 358 - 360
  • [40] A RANDOMIZED TRIAL OF MACC CHEMOTHERAPY WITH OR WITHOUT LONIDAMINE IN ADVANCED NONSMALL CELL LUNG-CANCER
    BUCCHERI, G
    FERRIGNO, D
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) : 1424 - 1431